Avastin Half Dose Demonstrates Similar Treatment Effect To Full Dose In NSCLC
This article was originally published in The Pink Sheet Daily
Executive Summary
Results of Genentech’s AVAiL trial could potentially have an impact on physician prescribing patterns for bevacizumab.